Literature DB >> 2245399

Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma.

J P Dutcher1, S L Marcus, H B Tanowitz, M Wittner, J Z Fuks, P H Wiernik.   

Abstract

A 45-year-old man presented with central nervous system involvement as the initial manifestation of disseminated infection with Strongyloides stercoralis. Several concurrent clinical factors contributed to this event, all related to the patient's immunosuppression, including high-grade lymphoma, corticosteroid therapy, and acquired immunodeficiency syndrome. This is only the third case of CNS involvement in disseminated strongyloidiasis diagnosed antemortem.

Entities:  

Mesh：

Year:  1990        PMID： 2245399     DOI： 10.1002/1097-0142(19901201)66:11<2417::aid-cncr2820661129>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 2.  Parasitic central nervous system infections in immunocompromised hosts.

Authors:  Melanie Walker; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

3.  First human case of fatal Halicephalobus gingivalis meningoencephalitis in Australia.

Authors:  Chuan Kok Lim; April Crawford; Casey V Moore; Robin B Gasser; Renjy Nelson; Anson V Koehler; Richard S Bradbury; Rick Speare; Deepak Dhatrak; Gerhard F Weldhagen
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

4.  Case Report: Central Nervous System Strongyloidiasis: Two Cases Diagnosed Antemortem.

Authors:  Jennifer Tam; Kevin L Schwartz; Jay Keystone; Dimitri Dimitrakoudis; Mark Downing; Sigmund Krajden
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

5.  Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature.

Authors:  S Morgello; F M Soifer; C S Lin; D E Wolfe
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 6.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 7.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

Review 8.  Strongyloidiasis--an insight into its global prevalence and management.

Authors:  Santhosh Puthiyakunnon; Swapna Boddu; Yiji Li; Xiaohong Zhou; Chunmei Wang; Juan Li; Xiaoguang Chen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

Review 9.  Strongyloides Stercoralis Infection Among Human Immunodeficiency Virus (HIV)-Infected Patients in the United States of America: A Case Report and Review of Literature.

Authors:  Laia Jimena Vazquez Guillamet; Zane Saul; Goran Miljkovich; Gabriel Alejandro Vilchez; Nikolai Mendonca; Venkata Gourineni; Nicholas Lillo; Marguerite Pinto; Aurengzaib Baig; Louie Mar Gangcuangco
Journal:  Am J Case Rep       Date:  2017-04-03

10.  Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy.

Authors:  Mónica Rodríguez; Paúl Flores; Víctor Ahumada; Lorena Vázquez-Vázquez; Claudia Alvarado-de la Barrera; Gustavo Reyes-Terán
Journal:  Case Rep Med       Date:  2012-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.